LI Yanan,XU Erping,ZHANG Rui,et al.ZHANG Lei's Experience in Treating Scleroderma from “Extraordinary Pathogens Entering Collaterals”[J].Journal of Traditional Chinese Medicine,2023,64(17):1745-1749.
LI Yanan,XU Erping,ZHANG Rui,et al.ZHANG Lei's Experience in Treating Scleroderma from “Extraordinary Pathogens Entering Collaterals”[J].Journal of Traditional Chinese Medicine,2023,64(17):1745-1749.DOI: 10.13288/j.11-2166/r.2023.17.004.
ZHANG Lei's Experience in Treating Scleroderma from “Extraordinary Pathogens Entering Collaterals”
This paper summarized professor ZHANG Lei′s experience in treating scleroderma from “extraordinary pathogens entering collaterals”. The basic pathogenesis of scleroderma is “extraordinary pathogens entering the collaterals”, and extraordinary pathogens can be divided into external and internal categories. External extraordinary pathogens are mostly exogenous wind, cold and damp pathogens, and the pathogenesis is wind, cold and damp invading skin stria and retaining collaterals. Most of the endogenous extraordinary pathogens are turbid phlegm and blood stasis, and the pathogenesis is endogenous phlegm and stasis leaving the channels and overflowing the collaterals, and blocking the collaterals. Blocked by extraordinary pathogens for a long time, the long illness will lead to deficiency and develop into a syndrome of collaterals excess and channels deficiency. Therefore, professor ZHANG creats
Tengluo Beverage
(藤络饮) as the basic formula to unblock collaterals and dispel pathogens, and recommends to add or subtract it according to the different syndrome and pathogenic characteristics of the edema stage, sclerosis stage, and atrophy stage. In the edema stage, it is advised to expel wind, remove dampness and unblock the collaterals, while in the sclerosis stage, the method of dissolving phlegm, expelling stasis and unblocking collaterals should be used; in the atrophic stage, it is suggested to differentiate the deficiency of
qi
, blood,
yin
and
yang
, and eliminate extraordinary pathogens on the basis of reinforcing healthy
MALTEZ N , HUGHES M , BROWN E , et al . Domain reporting in systemic sclerosis-related Raynaud's phenomenon: An OMERACT scoping review [J]. Semin Arthritis Rheum , 2023 , 61 : 152208 . doi: 10.1016/j.semarthrit. 2023.152208 http://dx.doi.org/10.1016/j.semarthrit.2023.152208 .